Analyst Reco. Shengtai Pharmaceutical, Inc.

Equities

Delayed OTC Markets Other stock markets 08:10:00 2023-12-11 pm EST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2013	Qingtai Liu, Chairman and Chief Executive Officer of Shengtai Pharmaceutical Inc. cancelled the acquisition of the remaining 59.5% stake in Shengtai Pharmaceutical Inc. from Pope Investments LLC, a fund of Pope Asset Management, LLC and other investors.	CI
2013	Shengtai Pharmaceutical Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2013	CI

No results for this search